Macular Degeneration Drug Prescribing Patterns After Step Therapy Introduction in Medicare Advantage
The findings of this retrospective encounter-based analysis indicate that step therapy is associated with a greater probability of prescribing the plan-preferred drug for the first administration. The analysis failed to find a statistically significant greater rate of medication switching within a treatment episode. Step therapy changed macular degeneration prescribing patterns, but step therapy alone did not transition all administrations to the plan-preferred drug.
Authors
- Kelly E. Anderson (ORCID: https://orcid.org/0000-0002-1471-6283)
- Gerard F. Anderson (ORCID: https://orcid.org/0000-0003-1845-1523)
- Thomas V. Johnson (ORCID: https://orcid.org/0000-0002-5372-5457)
- Daniel Polsky (ORCID: https://orcid.org/0000-0001-8403-9612)
- Joseph F Levy (ORCID: https://orcid.org/0000-0002-9317-5306)
- Angela Liu (ORCID: https://orcid.org/0000-0002-6822-1796)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1001/jamahealthforum.2024.2446
- Citations
- 2
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Johns Hopkins University
- Agency for Healthcare Research and Quality
- Johns Hopkins Bloomberg School of Public Health